<?xml version="1.0" encoding="UTF-8"?>
<p id="Par71">Patients who did not achieve SVR-12 were mostly males (76.5% vs 45.7% in responders patient, 
 <italic>p</italic> = 0.020), younger (51.6 vs 61.8, 
 <italic>p</italic> = 0.038), more frequently intravenous drug users (52.9% vs 22%, 
 <italic>p</italic> = 0.014) and presented a higher rate of failure to a previous anti-HCV treatment (47.0% vs 18.9%, 
 <italic>p</italic> = 0.024). The proportion of patients not achieving SVR-12 was higher among patients who underwent a change of the psychiatric regimen before anti-HCV treatment (6/20 patients, 30%) compared to those who maintained the same psychiatric therapy (11/124, 8.8%) (
 <italic>p</italic> = 0.015). On the contrary, no differences were observed according to ART change before anti-HCV treatment (no patient failed among those changing ART before baseline while only two failures were evidenced among the remaining subjects).
</p>
